GGrantIndex
Sort

172,184 grants matching inflammation

Inhibition Of Renal Injury

$997,543
Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK

STDS AND HETEROSEXUAL 'BRIDGING'AMONG MEN WHO HAVE SEX

$997,486
University Of Washington · U01 · FY2005 · AI

Center for Cellular Metabolism Research in Oklahoma

$997,408
Lijun Xia · Oklahoma Medical Research Foundation · P20 · FY2024 · GM

Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds

$997,264
Gautam Sudhir Ghatnekar · Xequel Bio, Inc. · R44 · FY2016 · DK

STING-dependent Intestinal Regeneration upon Radiation Injury

$997,217
Jian Yu · University Of Southern California · R01 · FY2025 · CA

Project 1: MiCAPP - Mechanisms of the CentrAlized Pain Phenotype

$997,215
Daniel J Clauw · University Of Michigan At Ann Arbor · P50 · FY2017 · AR

Targeting lipid rafts for treatment of asthma

$997,203
Yakov Kogan · Raft Pharmaceuticals, Llc · R44 · FY2024 · AI

Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease

$997,077
Charles T Roberts · Oregon Health & Science University · R01 · FY2025 · DK

Role of NKG2 Family Receptors in Regulating the Immune Response

$996,998
John E Coligan · Niaid Extramural Activities · Z01 · FY2007 · AI

All-Human Microphysical Model of Metastasis Therapy

$996,993
Linda G. Griffith · Massachusetts Institute Of Technology · UH3 · FY2016 · TR

Realization of Optical Cell-based Reporters for in vivo Detection of Neuropeptides

$996,914
Paul A Slesinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · MH

Preeclampsia and the Brain: Small vessel disease and cognitive function in early midlife

$996,791
Janet M Catov · Magee-Women'S Res Inst And Foundation · R01 · FY2024 · AG

Osteoporotic Fractures in Men (MrOS) - Minneapolis

$996,684
Kristine Ensrud · University Of Minnesota · U01 · FY2015 · AG

Systemic regulation of metastasis

$996,660
David Charles Lyden · Weill Medical Coll Of Cornell Univ · R35 · FY2022 · CA

Mechanisms of Platelet Activity in Vascular Disease

$996,660
Jeffrey S Berger · New York University School Of Medicine · R35 · FY2024 · HL

Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds

$996,533
Gautam Sudhir Ghatnekar · Xequel Bio, Inc. · R44 · FY2015 · DK

The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury

$996,529
Stavros Garantziotis · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES

Ultra-low distortion and noise electronics to enable a clinical MPI imaging platform

$996,469
Patrick Goodwill · Magnetic Insight, Inc. · R44 · FY2024 · EB

Host Directed Orynotide for MDR Gram Negative Bacterial Infections

$996,458
Justin Blaine Schaal · University Of Southern California · R01 · FY2024 · AI

Bacterial-Induced Sepsis: A New Treatment Strategy

$996,265
Sharon L McCoy · 13therapeutics, Inc. · R44 · FY2012 · AI

Sulfated Non-Anticoagulant Heparin Nanoparticle (VVP728) for Sickle Cell Disease Management

$996,212
Bozena Korczak · Vascular Vision Pharmaceuticals Company · R44 · FY2022 · HL

Mechanistic studies on stress, brain inflammation and neuroprotection

$996,062
Juan M Saavedra · National Institute Of Mental Health · ZIA · FY2012 · MH

Role of the microbiota in regulating the mononuclear phagocyte system

$996,061
Silvana Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Innate Immune Protection by Clean Genome E. coli

$995,989
Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2011 · AI

Opiate drug abuse and CNS vulnerability to HIV

$995,804
Kurt Francis Hauser · Virginia Commonwealth University · P01 · FY2008 · DA